Autoplaque vs syngo.via MI Workflows
AI Verdict
Choose Autoplaque if…
Choose Autoplaque if your primary need is highly specialized, AI-powered quantitative analysis of coronary plaques and luminal stenoses directly from CT angiography images. This tool is ideal for clinicians focused on precise heart attack risk prediction and guiding treatment strategies based on detailed coronary artery pathology.
View Autoplaque →Choose syngo.via MI Workflows if…
Choose syngo.via MI Workflows if you require a comprehensive, multi-modality imaging solution for advanced visualization and quantitative analysis across oncology, cardiology, and neurology, particularly for PET and SPECT studies. This platform is best suited for streamlining diagnostic workflows and integrating findings from various imaging sources within a flexible, enterprise-level environment.
View syngo.via MI Workflows →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Autoplaque | syngo.via MI Workflows |
|---|---|---|
| Pricing | Unknown | Subscription |
| Deployment | Workstation-based post-processing application, runs on Windows or Mac OS. | On premise, hybrid |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
syngo.via MI Workflowssyngo.via MI Workflows emphasizes automated workflows, smart layouts, and a Findings Navigator, which are designed to streamline complex diagnostic processes across multiple modalities. This focus on reducing manual steps and enhancing efficiency for a broader range of tasks suggests a more comprehensive and potentially smoother user experience compared to Autoplaque's workstation-based, specific analysis.
Clinical Value
TieBoth tools are FDA-cleared and offer significant clinical value, albeit in different scopes. Autoplaque provides highly specialized, quantitative analysis of coronary plaques for heart attack risk prediction, addressing a critical need in cardiology. syngo.via MI Workflows offers broader multi-modality quantitative analysis across oncology, cardiology, and neurology, streamlining diagnostic workflows for diverse conditions. Their respective impacts are substantial but distinct.
Pricing & Value
syngo.via MI Workflowssyngo.via MI Workflows offers a transparent subscription model with flexible clinical package access, allowing potential customers to understand and budget for the solution. Autoplaque's pricing is not disclosed, which makes it impossible to assess its value proposition or compare costs effectively.
Enterprise Readiness
syngo.via MI Workflowssyngo.via MI Workflows explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are crucial for enterprise healthcare deployments. Its deployment on the established Siemens syngo.via platform also indicates a robust, integrated solution suitable for large organizations, whereas Autoplaque's workstation-based deployment lacks these explicit enterprise-level compliance and integration details.
Innovation
syngo.via MI WorkflowsWhile Autoplaque demonstrates innovative depth in AI-powered quantitative analysis of coronary plaque, syngo.via MI Workflows showcases broader innovation. Its ALPHA Technology for automated anatomical alignment, multi-modality fusion, and integrated AI-enabled features for enhanced diagnostic workflows across various specialties represent a more comprehensive application of AI for streamlining complex processes.
Support & Docs
syngo.via MI WorkflowsAs a product from Siemens Healthineers, syngo.via MI Workflows benefits from the company's extensive global support infrastructure, professional services, and comprehensive documentation typical of a leading medical technology provider. Autoplaque, developed by a research institution, is less likely to offer the same level of formalized enterprise-grade support and documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Autoplaque | syngo.via MI Workflows |
|---|---|---|
| Name | Autoplaque | syngo.via MI Workflows |
| Company | Cedars-Sinai Medical Center: AIM | Siemens Medical Solutions USA |
| Description | Autoplaque, developed by Cedars-Sinai AIM, is an FDA-cleared AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. | syngo.via MI Workflows by Siemens Healthineers is an intelligent, multi-modality imaging software for 3D reading, advanced visualization, and quantitative analysis of PET and SPECT cases, streamlining diagnostic workflows in oncology, cardiology, and neurology. |
| Key Features | AI-powered quantitative analysis of atherosclerotic plaque; Detection and characterization of coronary artery plaque; Measurement of luminal stenoses; Analysis of coronary anatomy and pathology from CT Angiographic images; Workstation-based post-processing application; Automated vessel, plaque, and lumen segmentation (reviewable and editable by clinician); Review of heart and coronary vessels in Multiplanar Reformatting (MPR), curved MPR, and straightened MPR views; Measurement of vessel diameter and area | Multi-modality Fusion (PET/CT, SPECT/CT, MR, CT, Planar, Mammography, Angiography, Ultrasound); Quantitative Analysis (SUV, PERCIST, RECIST, EQu2022PET for scanner harmonization); ALPHA Technology (Automatic Landmarking and Parsing of Human Anatomy for alignment); Automated Workflows (Pre-fetching, Smart Layout, Organ Processing); Findings Navigator (stores and redisplays previous findings); AI-enabled features for enhanced diagnostic workflow; Disease-specific report templates; 3D visualization and advanced post-processing |
| Specialties | Cardiology, Radiology | Nuclear Medicine, Oncology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Autoplaque and syngo.via MI Workflows.